EPISODE · Sep 23, 2025 · 2 MIN
肿瘤里的“兵王”是如何与癌症对抗的?
from 天方烨谈
在肿瘤治疗领域,肿瘤浸润淋巴细胞(TIL)疗法是被很多专家看好的一种颠覆性技术。2024年美国食品药品监督管理局批准上市了全球首款TIL药物,也是全球首个获批用于实体瘤的 T 细胞疗法,标志着实体瘤治疗有了新式“武器”。
Embed this episode
NOW PLAYING
肿瘤里的“兵王”是如何与癌症对抗的?
0:00
2:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 天方烨谈?
This episode is 2 minutes long.
When was this 天方烨谈 episode published?
This episode was published on September 23, 2025.
Can I download this 天方烨谈 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!